Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness.

NCT00067938 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00067938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00067938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness.
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2003
Completion date
August 31, 2004
Enrollment
1,200 (actual)
Sites
308

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder